India likely to approve two-dose regimen for COVID vaccines, 4 weeks apart

India's drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.

>>Reuters
Published : 3 Jan 2021, 06:01 AM
Updated : 3 Jan 2021, 06:01 AM

Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines and a final decision is expected to be announced by the agency's chief at a news conference scheduled on Sunday.

Calls to CDSCO were unanswered outside regular business hours.